Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1970 1
1974 1
1976 3
1979 1
1980 4
1981 3
1982 7
1983 4
1984 7
1985 3
1986 1
1987 8
1988 4
1989 4
1990 3
1991 6
1992 4
1993 5
1994 3
1995 6
1996 6
1997 11
1998 8
1999 10
2000 6
2001 3
2002 6
2003 5
2004 3
2006 1
2007 3
2008 4
2009 7
2010 6
2011 4
2012 5
2013 4
2014 2
2015 4
2017 3
2018 3
2019 3
2020 1
2021 1
2022 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

180 results

Results by year

Filters applied: . Clear all
Page 1
CD19-targeted T cells rapidly induce molecular remissions in adults with chemotherapy-refractory acute lymphoblastic leukemia.
Brentjens RJ, Davila ML, Riviere I, Park J, Wang X, Cowell LG, Bartido S, Stefanski J, Taylor C, Olszewska M, Borquez-Ojeda O, Qu J, Wasielewska T, He Q, Bernal Y, Rijo IV, Hedvat C, Kobos R, Curran K, Steinherz P, Jurcic J, Rosenblat T, Maslak P, Frattini M, Sadelain M. Brentjens RJ, et al. Among authors: steinherz p. Sci Transl Med. 2013 Mar 20;5(177):177ra38. doi: 10.1126/scitranslmed.3005930. Sci Transl Med. 2013. PMID: 23515080 Free PMC article. Clinical Trial.
Methotrexate, Doxorubicin, and Cisplatin (MAP) Plus Maintenance Pegylated Interferon Alfa-2b Versus MAP Alone in Patients With Resectable High-Grade Osteosarcoma and Good Histologic Response to Preoperative MAP: First Results of the EURAMOS-1 Good Response Randomized Controlled Trial.
Bielack SS, Smeland S, Whelan JS, Marina N, Jovic G, Hook JM, Krailo MD, Gebhardt M, Pápai Z, Meyer J, Nadel H, Randall RL, Deffenbaugh C, Nagarajan R, Brennan B, Letson GD, Teot LA, Goorin A, Baumhoer D, Kager L, Werner M, Lau CC, Sundby Hall K, Gelderblom H, Meyers P, Gorlick R, Windhager R, Helmke K, Eriksson M, Hoogerbrugge PM, Schomberg P, Tunn PU, Kühne T, Jürgens H, van den Berg H, Böhling T, Picton S, Renard M, Reichardt P, Gerss J, Butterfass-Bahloul T, Morris C, Hogendoorn PC, Seddon B, Calaminus G, Michelagnoli M, Dhooge C, Sydes MR, Bernstein M; EURAMOS-1 investigators. Bielack SS, et al. J Clin Oncol. 2015 Jul 10;33(20):2279-87. doi: 10.1200/JCO.2014.60.0734. Epub 2015 Jun 1. J Clin Oncol. 2015. PMID: 26033801 Free PMC article. Clinical Trial.
Pediatric leukemia/lymphoma with t(8;14)(q24;q11).
Lange BJ, Raimondi SC, Heerema N, Nowell PC, Minowada J, Steinherz PE, Arenson EB, O'Connor R, Santoli D. Lange BJ, et al. Among authors: steinherz pe. Leukemia. 1992 Jul;6(7):613-8. Leukemia. 1992. PMID: 1385638 Review.
Pediatric AML: past, present, and future.
Onel K, Steinherz PG. Onel K, et al. Among authors: steinherz pg. Cancer Invest. 2002;20(7-8):1117. doi: 10.1081/cnv-120005931. Cancer Invest. 2002. PMID: 12449745 No abstract available.
Vincristine and platelet function.
Steinherz PG, Miller DR. Steinherz PG, et al. JAMA. 1982 Oct 22;248(16):1974-5. doi: 10.1001/jama.1982.03330160026014. JAMA. 1982. PMID: 7120623 No abstract available.
A case of KMT2A-SEPT9 fusion-associated acute megakaryoblastic leukemia.
Forlenza CJ, Zhang Y, Yao J, Benayed R, Steinherz P, Ramaswamy K, Kessel R, Roshal M, Shukla N. Forlenza CJ, et al. Among authors: steinherz p. Cold Spring Harb Mol Case Stud. 2018 Dec 17;4(6):a003426. doi: 10.1101/mcs.a003426. Print 2018 Dec. Cold Spring Harb Mol Case Stud. 2018. PMID: 30455225 Free PMC article.
180 results